WFRV/HealthWatch: Lifting brain fog with virtual music therapy
University of Cincinnati researchers' pilot study provides do-it-yourself intervention through app
Patients who have been infected with COVID-19 or who have gone through medical treatment like chemotherapy often report brain fog, described as issues with thinking, remembering or focusing.
University of Cincinnati researchers led by Soma Sengupta, MD, PhD, associate professor and Harold C. Schott Endowed Chair of Molecular Therapeutics in the Department of Neurology and a UC Health neuro-oncologist; and Claudia Rebola, PhD, associate dean for research, associate professor and director of the new Center for DAAP Research and Innovation (CDRI) on Health and Wellbeing in the College of Design, Architecture, Art, and Planning, are leading a pilot study examining music therapy's effect on brain fog through a mobile app.
Patients in the study are assigned to groups that either listen to music or actively make their own music through the app.
“These technologies are sort of in a way helping the rewiring and exercising areas of the brain that normally wouldn’t do it,” Sengupta told WFRV's HealthWatch.
Featured photo of ARMCan app in use courtesy of Claudia Rebola, PhD.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
UC Board votes to fund design for YMCA renovation
October 28, 2025
At its October 28, 2025 meeting, the University of Cincinnati Board of Trustees approved $5 million in funding to complete all design and pre-construction services required to renovate the interior of a former YMCA building located at 270 Calhoun Street.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.